The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

70 articles for YS Lee


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects.EBI
Seoul National University
Identification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism.EBI
Kyung Hee University
Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors.EBI
Korea Institute of Science and Technology
Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors.EBI
Kyung Hee University
Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.EBI
University of Arizona
Discovery of 4-aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 inhibitors. Part I: optimization of in vitro potencies and pharmacokinetic properties.EBI
Development Center For Biotechnology
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.EBI
Kyung Hee University
Synthesis, characterization and Akt phosphorylation inhibitory activity of cyclopentanecarboxylate-substituted alkylphosphocholines.EBI
Kyung Hee University
Synthesis and structure-activity relationships of tri-substituted thiazoles as RAGE antagonists for the treatment of Alzheimer's disease.EBI
Korea Institute of Science and Technology
Discovery of potent and selective rhodanine type IKKß inhibitors by hit-to-lead strategy.EBI
Korea University
Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.EBI
University of Arizona
Design and synthesis of calpain inhibitory 6-pyridone 2-carboxamide derivatives.EBI
Kyung Hee University
Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.EBI
Shenyang Pharmaceutical University
Design and synthesis of novel hydrazide-linked bifunctional peptides as delta/mu opioid receptor agonists and CCK-1/CCK-2 receptor antagonists.EBI
University of Arizona
Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.EBI
Korea Institute of Science & Technology
Molecular modeling studies of aldose reductase inhibitors.EBI
National Eye Institute
A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.EBI
Korea Institute of Science & Technology
Synthesis and HIV-1 integrase inhibitory activities of caffeoylglucosides.EBI
Institute of Science and Technology
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selectiveµ-antagonist activity.EBI
National Institute On Drug Abuse and The National Institute On Alcohol Abuse and Alcoholism
Synthesis and biological evaluation of 4-piperidinecarboxylate and 4-piperidinecyanide derivatives for T-type calcium channel blockers.EBI
Korea Institute of Science and Technology
Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.EBI
College of Pharmacy Kyung Hee University
Probes for narcotic receptor mediated phenomena. 41. Unusual inverseµ-agonists and potentµ-opioid antagonists by modification of the N-substituent in enantiomeric 5-(3-hydroxyphenyl)morphans.EBI
National Institute On Drug Abuse
Molecular basis of cyclin-CDK-CKI regulation by reversible binding of an inositol pyrophosphate.EBI
Harvard University
Discovery of pyrrole-indoline-2-ones as Aurora kinase inhibitors with a different inhibition profile.EBI
Development Center For Biotechnology
Probes for narcotic receptor mediated phenomena. 40. N-substituted cis-4a-ethyl-1,2,3,4,4a,9a-hexahydrobenzofuro[2,3-c]pyridin-8-ols.EBI
Nida
Kojic acid-amino acid conjugates as tyrosinase inhibitors.EBI
Seoul National University
Probes for narcotic receptor mediated phenomena. 39. Enantiomeric N-substituted benzofuro[2,3-c]pyridin-6-ols: synthesis and topological relationship to oxide-bridged phenylmorphans.EBI
National Institute On Drug Abuse and The National Institute On Alcohol Abuse and Alcoholi
Probes for narcotic receptor mediated phenomena. 37. Synthesis and opioid binding affinity of the final pair of oxide-bridged phenylmorphans, the ortho- and para-b-isomers and their N-phenethyl analogues, and the synthesis of the N-phenethyl analogues of the ortho- and para-d-isomers.EBI
National Institute On Drug Abuse
Synthesis of tyrosinase inhibitory (4-oxo-4H-pyran-2-yl)acrylic acid ester derivatives.EBI
Institute of Science and Technology
Synthesis and evaluation of alpha,alpha'-disubstituted phenylacetate derivatives for T-type calcium channel blockers.EBI
Institute of Science and Technology
Synthesis and biological evaluation of O4'-benzyl-hispidol derivatives and analogs as dual monoamine oxidase-B inhibitors and anti-neuroinflammatory agents.EBI
Mansoura University
Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors.EBI
Kyung Hee University
Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.EBI
Crystalgenomics
Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.EBI
National Institute On Drug Abuse
Identification and Biological Evaluation of a Potent and Selective JAK1 Inhibitor for the Treatment of Pulmonary Fibrosis.EBI
Ewha Womans University
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders.EBI
National Institute On Alcohol Abuse and Alcoholism (NIAAA)
Understanding the structural requirements of 4-anilidopiperidine analogues for biological activities at mu and delta opioid receptors.EBI
University of Arizona
Partial retro-inverso, retro, and inverso modifications of hydrazide linked bifunctional peptides for opioid and cholecystokinin (CCK) receptors.EBI
University of Arizona
Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity.EBI
University of Arizona
Pharmacophore-based virtual screening: the discovery of novel methionyl-tRNA synthetase inhibitors.EBI
Seoul National University
Novel potent antagonists of transient receptor potential channel, vanilloid subfamily member 1: structure-activity relationship of 1,3-diarylalkyl thioureas possessing new vanilloid equivalents.EBI
Seoul National University
Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.EBI
Seoul National University
Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.EBI
Seoul National University
Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.EBI
Institute of Science & Technology
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters.EBI
University of The Punjab
Synthesis, Biological Evaluation, and Molecular Modeling Studies of 3,4-Diarylpyrazoline Series of Compounds as Potent, Nonbrain Penetrant Antagonists of Cannabinoid-1 (CBEBI
National Institute On Alcohol Abuse and Alcoholism
Synthesis and anti-inflammatory effects of novel pimarane diterpenoid analogs.EBI
Seoul National University
3,4-Dihydroquinazoline derivatives as novel selective T-type Ca2+ channel blockers.EBI
Institute of Science & Technology
Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity.EBI
Seoul National University
Catechol-substituted L-chicoric acid analogues as HIV integrase inhibitors.EBI
Institute of Science & Technology
Structure-Activity Relationships of [des-ArgEBI
University of Arizona
Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson's disease.EBI
Korea Institute of Science & Technology (Kist)
Anti-glioma effects of 2-aminothiophene-3-carboxamide derivatives, ANO1 channel blockers.EBI
Korea University
G-Protein biased opioid agonists: 3-hydroxy-EBI
National Institute On Drug Abuse
6-Hydroxy-1,3-dioxin-4-ones as non-peptidic HIV protease inhibitors.EBI
Institute of Science & Technology
A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model.EBI
Korea Institute of Science & Technology (Kist)
Chiral Effect of a Phe Residue in Position 3 of the DmtEBI
University of Arizona
Effect of anchoring 4-anilidopiperidines to opioid peptides.EBI
University of Arizona
Synthesis and dual biological effects of hydroxycinnamoyl phenylalanyl/prolyl hydroxamic acid derivatives as tyrosinase inhibitor and antioxidant.EBI
Seoul National University
Small molecules that protect against β-amyloid-induced cytotoxicity by inhibiting aggregation of β-amyloid.EBI
Korea Institute of Science and Technology
Vanillic acid glycoside and quinic acid derivatives from Gardeniae Fructus.EBI
Korea Institute of Science and Technology
Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.EBI
Korea Institute of Science & Technology
Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy.EBI
Yonsei University
Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CBEBI
Kyung Hee University
Cyclic biphalin analogues with a novel linker lead to potent agonist activities at mu, delta, and kappa opioid receptors.EBI
University of Arizona
Modulation of opioid receptor affinity and efficacy via N-substitution of 9β-hydroxy-5-(3-hydroxyphenyl)morphan: Synthesis and computer simulation study.EBI
National Institute On Drug Abuse and The National Institute On Alcohol Abuse
ImmunomodulatorsBDB
Bristol-Myers Squibb
3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).BDB
Smithkline Beecham Pharmaceuticals